PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis b |
| Phenotype | C0011849|diabetes mellitus |
| Sentences | 8 |
| PubMedID- 23493666 | The clinical characteristics were collected in table 1, including gender, age, alcohol drinking, tobacco smoking, hypertension, diabetes mellitus, family history of hcc, hepatitis b virus ( hbv) serological markers, and serum alpha-fetoprotein (a-fp) levels. |
| PubMedID- 26332473 | Educational intervention in primary care residents' knowledge and performance of hepatitis b vaccination in patients with diabetes mellitus. |
| PubMedID- 22920812 | Introduction: the risk of acute hepatitis b among adults with diabetes mellitus is unknown. |
| PubMedID- 24843742 | hepatitis b virus-associated nephropathy in a patient with diabetes mellitus. |
| PubMedID- 25270965 | Above well-known risk factors for hcc development ranging from various toxins to diseases such as diabetes mellitus, chronic infection with hepatitis b virus and hepatitis c virus (hcv) poses the most serious threat, constituting the cause in more than 80 % of cases. |
| PubMedID- 24932351 | Prevalence of hepatitis b virus in patients with diabetes mellitus: a comparative cross sectional study at woldiya general hospital, ethiopia. |
| PubMedID- 21799928 | They included sex, age, baseline laboratory data: cd4 cell count, hiv viral load, and serum creatinine, and other medical conditions (antiretroviral treatment-naïve or experienced, concurrent ritonavir-boosted protease inhibitors, concurrent nephrotoxic drugs such as ganciclovir, sulfamethoxazole/trimethoprim, ciprofloxacin, and nsaids, diabetes mellitus, co-infection with hepatitis b defined by positive hepatitis b surface antigen, co-infection with hepatitis c defined by positive hcv viral load, hypertension defined by current treatment with antihypertensive agents, dyslipidemia defined by current treatment with lipid-lowering agents, and current smoking) [26]. |
| PubMedID- 22505448 | Chronic hepatitis b with type i diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy. |
Page: 1